Polyclonal Rabbit anti‑Human CCNB2 / Cyclin B2 Antibody (APC, aa58‑398, WB) LS‑C718262
Polyclonal Rabbit anti‑Human CCNB2 / Cyclin B2 Antibody (APC, aa58‑398, WB) LS‑C718262
Antibody:
CCNB2 / Cyclin B2 Rabbit anti-Human Polyclonal (aa58-398) (APC) Antibody
Format:
Allophycocyanin, Unmodified
Overview
Antibody:
CCNB2 / Cyclin B2 Rabbit anti-Human Polyclonal (aa58-398) (APC) Antibody
Format:
Allophycocyanin, Unmodified
Specifications
Description
Cyclin B2 antibody LS-C718262 is an APC-conjugated rabbit polyclonal antibody to Cyclin B2 (CCNB2) (aa58-398) from human. It is reactive with human and mouse. Validated for WB.
Target
Human CCNB2 / Cyclin B2
Synonyms
CCNB2 | Cyclin B2 | G2/mitotic-specific cyclin-B2 | HsT17299
Reactivity
Human, Mouse
(tested or 100% immunogen sequence identity)
Conjugations
Allophycocyanin.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
Cy3,
HRP,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant CCNB2 (Val58-Ser398)
Specificity
The antibody is a rabbit polyclonal antibody raised against CCNB2.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
Western blot
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Source:
E. coli
Tag:
His, N-Terminal
Reactivity:
Mouse
Range:
0.312-20 ng/ml
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/29/2024